Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lucchese, Fabienne"'
Autor:
Martins, Christina, Migayron, Laure, Drullion, Claire, Jacquemin, Clément, Lucchese, Fabienne, Rambert, Jérôme, Merhi, Ribal, Michon, Pauline, Taieb, Alain, Rezvani, Hamid-Reza, de Rinaldis, Emanuele, Seneschal, Julien, Boniface, Katia
Publikováno v:
In Journal of Investigative Dermatology September 2021
Autor:
Jacquemin, Clément, Martins, Christina, Lucchese, Fabienne, Thiolat, Denis, Taieb, Alain, Seneschal, Julien, Boniface, Katia
Publikováno v:
In Journal of Investigative Dermatology June 2020 140(6):1143-1153
Autor:
Boniface, Katia, Jacquemin, Clément, Darrigade, Anne-Sophie, Dessarthe, Benoît, Martins, Christina, Boukhedouni, Nesrine, Vernisse, Charlotte, Grasseau, Alexis, Thiolat, Denis, Rambert, Jérôme, Lucchese, Fabienne, Bertolotti, Antoine, Ezzedine, Khaled, Taieb, Alain, Seneschal, Julien
Publikováno v:
In Journal of Investigative Dermatology February 2018 138(2):355-364
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
BOUKHEDOUNI, Nesrine, Martins, Christina, Darrigade, Anne-Sophie, Drullion, Claire, RAMBERT, Jérôme, Barrault, Christine, Garnier, Julien, JACQUEMIN, Clement, THIOLAT, Denis, LUCCHESE, Fabienne, MOREL, Franck, Ezzedine, Khaled, Taieb, Alain, Bernard, François-Xavier, Seneschal, Julien, boniface, katia, Boniface1, Katia
Publikováno v:
JCI Insight
JCI Insight, American Society for Clinical Investigation, 2020, 5 (11), pp.e133772. ⟨10.1172/jci.insight.133772⟩
JCI Insight, American Society for Clinical Investigation, 2020, 5 (11), pp.e133772. ⟨10.1172/jci.insight.133772⟩
International audience; Loss of melanocytes is the pathological hallmark of vitiligo, a chronic inflammatory skin depigmenting disorder induced by exaggerated immune response, including autoreactive CD8 T cells producing high levels of type 1 cytokin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fa109c21cf4109a894aeed428daf050c
http://hdl.handle.net/20.500.12278/123881
http://hdl.handle.net/20.500.12278/123881
Autor:
Boukhedouni, Nesrine, Jacquemin, Clément, Darrigade, Anne-Sophie, Dessarthe, Benoît, Rambert, Jérôme, Thiolat, Denis, Lucchese, Fabienne, Bertolotti, Antoine, Taieb, Alain, Ezzedine, Khaled, Seneschal, Julien, Boniface, Katia
Publikováno v:
In Annales de dermatologie et de venereologie December 2016 143(12) Supplement:S423-S423
Autor:
Guillet, Stéphanie, Rambert, Jérôme, Lucchese, Fabienne, Thiolat, Denis, Blanco, Patrick, Taieb, Alain, Boniface, Katia, Seneschal, Julien
Publikováno v:
In Annales de dermatologie et de venereologie June-July 2015 142(6-7) Supplement 1:S288-S288
Autor:
Boukhedouni N; INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC), Immunodermatology ATIP-AVENIR, University of Bordeaux, FHU ACRONIM, Bordeaux, France., Martins C; INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC), Immunodermatology ATIP-AVENIR, University of Bordeaux, FHU ACRONIM, Bordeaux, France., Darrigade AS; INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC), Immunodermatology ATIP-AVENIR, University of Bordeaux, FHU ACRONIM, Bordeaux, France.; Department of Dermatology and Pediatric Dermatology and National Reference Center for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France., Drullion C; INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC), Immunodermatology ATIP-AVENIR, University of Bordeaux, FHU ACRONIM, Bordeaux, France., Rambert J; AquiDerm, University of Bordeaux, Bordeaux, France., Barrault C; Bioalternatives, Gençay, France., Garnier J; Bioalternatives, Gençay, France., Jacquemin C; INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC), Immunodermatology ATIP-AVENIR, University of Bordeaux, FHU ACRONIM, Bordeaux, France., Thiolat D; INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC), Immunodermatology ATIP-AVENIR, University of Bordeaux, FHU ACRONIM, Bordeaux, France., Lucchese F; INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC), Immunodermatology ATIP-AVENIR, University of Bordeaux, FHU ACRONIM, Bordeaux, France., Morel F; Laboratoire Inflammation, Tissus Epithéliaux et Cytokines, University of Poitiers, Poitiers, France., Ezzedine K; Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Hôpital Henri-Mondor, Créteil, France., Taieb A; Department of Dermatology and Pediatric Dermatology and National Reference Center for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France., Bernard FX; Bioalternatives, Gençay, France., Seneschal J; INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC), Immunodermatology ATIP-AVENIR, University of Bordeaux, FHU ACRONIM, Bordeaux, France.; Department of Dermatology and Pediatric Dermatology and National Reference Center for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France., Boniface K; INSERM U1035, Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC), Immunodermatology ATIP-AVENIR, University of Bordeaux, FHU ACRONIM, Bordeaux, France.
Publikováno v:
JCI insight [JCI Insight] 2020 Jun 04; Vol. 5 (11). Date of Electronic Publication: 2020 Jun 04.